MDT

99.8

-0.46%↓

A

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

MDT

99.8

-0.46%↓

A

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

MDT

99.8

-0.46%↓

A

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

MDT

99.8

-0.46%↓

A

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

MDT

99.8

-0.46%↓

A

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

Search

Astrana Health Inc

Geschlossen

BrancheGesundheitswesen

27.98 0.29

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

26.69

Max

28.16

Schlüsselkennzahlen

By Trading Economics

Einkommen

-9.8M

373K

Verkäufe

301M

956M

KGV

Branchendurchschnitt

130.476

87.826

Gewinnspanne

0.039

Angestellte

1,900

EBITDA

7.9M

39M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+12.54% upside

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-148M

1.4B

Vorheriger Eröffnungskurs

27.69

Vorheriger Schlusskurs

27.98

Nachrichtenstimmung

By Acuity

34%

66%

106 / 372 Ranking in Healthcare

Astrana Health Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

7. Jan. 2026, 23:11 UTC

Ergebnisse

Samsung Electronics Expects Record Fourth-Quarter Profit Beat

7. Jan. 2026, 22:55 UTC

Wichtige Markttreiber

Defense Stocks Rebound After Trump Says He Wants $1.5 Trillion Military Budget in 2027

7. Jan. 2026, 21:39 UTC

Wichtige Markttreiber

Raytheon Down Following Trump Post Criticizing Company

7. Jan. 2026, 20:13 UTC

Wichtige Markttreiber

AbbVie, Revolution Medicines Stocks Gain on Report of Possible Acquisition

7. Jan. 2026, 20:03 UTC

Wichtige Markttreiber

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Executive Pay

7. Jan. 2026, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

7. Jan. 2026, 23:46 UTC

Market Talk

Nikkei May Decline as China-Japan Tensions Linger -- Market Talk

7. Jan. 2026, 23:42 UTC

Akquisitionen, Fusionen, Übernahmen

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 5th Update

7. Jan. 2026, 23:34 UTC

Market Talk

Gold Edges Higher Amid Lingering Geopolitical Risks -- Market Talk

7. Jan. 2026, 23:29 UTC

Akquisitionen, Fusionen, Übernahmen

Constellation Closes Deal for Calpine, Creating Biggest Electricity Generator -- Barrons.com

7. Jan. 2026, 22:48 UTC

Market Talk

Infratil's Discount to Net Asset Value Too Good to Ignore -- Market Talk

7. Jan. 2026, 22:46 UTC

Ergebnisse

Samsung Electronics Estimates 2025 Rev KRW332.770T Vs KRW300.870T >005930.SE

7. Jan. 2026, 22:45 UTC

Ergebnisse

Samsung Electronics Estimates 2025 Oper Pft KRW43.530T Vs KRW32.730T >005930.SE

7. Jan. 2026, 22:43 UTC

Akquisitionen, Fusionen, Übernahmen

Revolution Medicines Draws Takeover Interest -- 2nd Update

7. Jan. 2026, 22:42 UTC

Ergebnisse

Samsung Electronics 4Q Oper Pft Estimate Beat FactSet-Compiled Consensus Forecast

7. Jan. 2026, 22:41 UTC

Ergebnisse

Samsung Electronics Sees 4Q Oper Pft KRW20.000T Vs KRW6.490T >005930.SE

7. Jan. 2026, 22:41 UTC

Ergebnisse

Samsung Electronics Sees 4Q Rev KRW93.000T Vs KRW75.790T >005930.SE

7. Jan. 2026, 22:40 UTC

Wichtige Markttreiber

Defense Stocks Rebound After Trump Says He Wants $1.5T Military Budget in 2027

7. Jan. 2026, 22:31 UTC

Market Talk

Macro Tailwinds Strengthen for Chalice Mining -- Market Talk

7. Jan. 2026, 22:22 UTC

Market Talk

Northern Star's Run of Disruptions Increasingly a Concern -- Market Talk

7. Jan. 2026, 22:01 UTC

Market Talk

Valuations of New Zealand Property Stocks Supportive -- Market Talk

7. Jan. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

7. Jan. 2026, 21:46 UTC

Market Talk

Northern Star's Revised Guidance Looks Achievable -- Market Talk

7. Jan. 2026, 21:22 UTC

Akquisitionen, Fusionen, Übernahmen

Eli Lilly to Buy Ventyx Biosciences for $14 a Share >LLY VTYX

7. Jan. 2026, 21:18 UTC

Akquisitionen, Fusionen, Übernahmen

Lilly To Acquire Ventyx Biosciences To Advance Oral Therapies Targeting Inflammatory-mediated Diseases >LLY VTYX

7. Jan. 2026, 21:05 UTC

Akquisitionen, Fusionen, Übernahmen

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 4th Update

7. Jan. 2026, 20:29 UTC

Akquisitionen, Fusionen, Übernahmen

AbbVie Near Deal for Revolution Medicines -- Update

7. Jan. 2026, 20:27 UTC

Market Talk

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

7. Jan. 2026, 19:58 UTC

Market Talk

Oil Falls As U.S. to Receive Sanctioned Venezuelan Crude -- Market Talk

7. Jan. 2026, 19:48 UTC

Wichtige Markttreiber

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Exec Pay

Peer-Vergleich

Kursveränderung

Astrana Health Inc Prognose

Kursziel

By TipRanks

12.54% Vorteil

12-Monats-Prognose

Durchschnitt 31.5 USD  12.54%

Hoch 37 USD

Tief 26 USD

Basierend auf 8 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Astrana Health Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

8 ratings

6

Buy

2

Halten

0

Sell

Stimmung

By Acuity

106 / 372 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Astrana Health Inc

Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.
help-icon Live chat